Galectin-7 is therefore being further investigated as a potential target for the specific detection and therapeutic inhibition of metastatic breast cancer.[18] In patients with breast cancer, galectin-7 was investigated as a prognostic marker and found to be associated with disease-free survival.[19]. This evidence concerns the gene LGALS7 and breast carcinoma.